Enforcement Report - Week of November 13, 2024
13 Nov 2024 //
FDA
Wanbury receives CEP certification for Dextromethorphan API from EDQM
09 Sep 2024 //
EXPRESSPHARMA
Enforcement Report - Week of January 10, 2024
10 Jan 2024 //
FDA
Enforcement Report - Week of June 7, 2023
07 Jun 2023 //
FDA
Nagpur paediatricians warn against rampant use of cough syrups
10 Oct 2022 //
ECONOMIC TIMES
Axsome Initiates Phase 3 Trial of axs-05 in Alzheimer’s Disease Agitation
09 Sep 2022 //
PRESS RELEASE
Axsome Therapeutics announces publication of pivotal ascend PII trial of AXS-05
18 May 2022 //
PRESS RELEASE
Enforcement Report - Week of May 4, 2022
04 May 2022 //
FDA
Enforcement Report - Week of February 9, 2022
09 Feb 2022 //
FDA
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Avanir Pharma to Continue Clinical Development of Investigational AVP-786
12 Nov 2019 //
PR NEWSWIRE
Reeling from a hefty civil and criminal settlement
30 Sep 2019 //
ENDPTS
Avanir agrees to pay $108M over Neudexta kickbacks probe
27 Sep 2019 //
FIERCE PHARMA
Otsuka’s Alzheimer’s agitation drug hits the mark
26 Mar 2019 //
PMLIVE
Otsuka expects to pay $120M to wrap the feds` Nuedexta probe
15 Feb 2019 //
FIERCE PHARMA
Enforcement Report - Week of June 20, 2018
20 Jun 2018 //
FDA
Medicare alert draws attention to use of laughing drug Nuedexta
04 Jun 2018 //
FIERCE PHARMA
Amneal Pharm’s Generic Dextromethorphan Polistirex Receives Approval In US
31 Jul 2017 //
FDA
How Ketamine could cure depression
30 Jan 2017 //
DRUG TARGET REVIEW
Eisai Acquires All Global Development & Marketing Rights For Lorcaserin HCI
05 Jan 2017 //
PR NEWSWIRE
Avanir shelves Danny Glover PBA awareness ad in favor of branded Nuedexta effort
21 Dec 2016 //
FIERCE PHARMA
200 out of 500 combinations examined have been found irrational: Govt sources
17 Nov 2016 //
BUSINESS STANDARD
Labeling Foul-Up Involving Acetaminophen Leads RB to Recall 135 Lots of Mucinex
24 Apr 2015 //
FIERCE PHARMA MANUFACTURING
Cough Medicine Ingredient May Aid Type 2 Diabetes Fight, Heinrich Heine University
18 Mar 2015 //
BIOSPACE
Actavis Will Appeal Injunction Requiring Continued Distribution of NAMENDA® IR
15 Dec 2014 //
ACTAVIS